Shayne Stokes, MD
Allergy & Immunology · Twin Falls, IDNPI 1225007644
Payments from drug & device makers
Across 260 payments — averaging $20.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$893
- GSK$712
- Regeneron Healthcare Solutions, Inc.$661
- Grifols USA, LLC$526
- CSL Behring$498
- Aimmune Therapeutics, Inc.$409
- plus $2K from 19 others
What the payments were for
- Consulting fees$240%
- Speaking & faculty fees$3507%
- Food & beverage$4,91092%
- Education$321%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 45 | $893 |
| GSK | 68 | $712 |
| Regeneron Healthcare Solutions, Inc. | 29 | $661 |
| Grifols USA, LLC | 24 | $526 |
| CSL Behring | 18 | $498 |
| Aimmune Therapeutics, Inc. | 5 | $409 |
| Blueprint Medicines Corporation | 7 | $308 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $231 |
| Sanofi | 8 | $167 |
| Mylan Specialty L.p. | 7 | $134 |
| Genentech USA, Inc. | 5 | $108 |
| Amgen(2 entities) | 5 | $96 |
| Novartis | 4 | $81 |
| Pharming Healthcare, Inc. | 3 | $77 |
| Teva Pharmaceuticals USA, Inc. | 5 | $72 |
| Biocryst US Sales Co., LLC | 3 | $71 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $64 |
| ADMA Biomanufacturing LLC | 2 | $47 |
| Ionis Pharmaceuticals, Inc. | 2 | $31 |
| Verona Pharma, Inc. | 1 | $27 |
| Jubilant Hollisterstier LLC | 1 | $26 |
| Pfizer | 1 | $23 |
| Lilly USA, LLC | 1 | $19 |
| Viatris Specialty LLC | 1 | $19 |
| Boehringer Ingelheim | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few allergy & immunology providers in Idahoto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 140 | $118,800 |
| TezspireTezepelumab-Ekko | 16 | $68,958 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 43 | $41,579 |
| Spiriva RespimatTiotropium Bromide | 23 | $24,353 |
| Breo ElliptaFluticasone/Vilanterol | 19 | $18,977 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 15 | $8,842 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 23 | $6,282 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 55 | $5,064 |
| BreynaBudesonide/Formoterol Fumarate | 21 | $4,203 |
| Azelastine Hcl | 168 | $3,408 |
| SymbicortBudesonide/Formoterol Fumarate | 12 | $3,351 |
| Epinephrine | 12 | $3,123 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 94 | $2,668 |
| Fluticasone Propionate | 134 | $2,210 |
| Ipratropium Bromide | 28 | $821 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta | $712 | $137,778159 claims |
| AstraZenecaTezspire, Breztri Aerosphere, Symbicort | $893 | $113,88771 claims |
| Boehringer IngelheimSpiriva Respimat, Combivent Respimat | $16 | $33,19538 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few allergy & immunology providers in Idahoon file to place this against a meaningful peer group, so we don't.
Other allergy & immunology in Twin Falls
- John JeppsonBoise$65K
- Wendell PettyIdaho Falls$12K
- George PalmerBoise$9K
- Michael KeileyBoise$7K
- Sean StoutBoise$5K
- Jeremy WaldramBoise$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.